Skip to content

The Experiences of Patients Living With Malignant Pleural Effusions

The Experiences of Patients Living With Malignant Pleural Effusions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03235999
Enrollment
10
Registered
2017-08-01
Start date
2016-06-02
Completion date
2019-01-14
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Pleural Effusion

Brief summary

Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.

Interventions

None listed

Sponsors

Gloucestershire Hospitals NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults diagnosed with a malignant pleural effusion 2. Has undergone either talc pleurodesis or IPC 3. Have signed a consent form prior to entering the study 4. Life expectancy \> 6 weeks based on LENT guidelines (Low/Moderate risk group) - The LENT score calculation assigns 0 (\<1500 IU/L) or 1 (\>1500 IU/L) for pleural fluid LDH level; 0 to 3 points for matching ECOG performance scores (3 and 4 are combined); 0 (\<9) or 1 (\>9) for neutrophil-to-lymphocyte ratio; and 0 (lowest risk), 1 (moderate risk), or 3 (highest risk) for tumor type.

Exclusion criteria

1. Any patient who is unable to understand sufficient English to take part in the semi-structured interviews 2. Weakness or fatigue sufficient so that the patient is unable to take part in the interviews

Design outcomes

Primary

MeasureTime frameDescription
Patient Experiences of living with malignant pleural effusion and different pleural procedures4 weeks after IPC placement or talc pleurodesisQualitative interviews - Interviews will be recorded on a digital audio recorder and then downloaded on to a password protected computer. The interviews will then be sent for transcription using secure email and anonymised. We will perform thematic analysis on the interview data. This is a process to help explore the experiences of the subject as they describe it rather than looking at how they talk about the experience. Themes will be drawn from the data following coding. Common codes relating to a theme, for example pain, will be identified and examples of text used to demonstrate the theme extracted. This will ensure a wide variety of quotes across the interviews rather than focusing on one main or a subset of interviews. We will use an inductive approach whereby themes will emerge and not be developed in advance. Emerging codes will be checked by the supervisory team. There will be no numerical, quantitative data for analysis.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026